What Patients Think about Hybrid and Decentralized Clinical Trials
• March 29, 2021
How Do Patients Feel about Hybrid and Decentralized Clinical Trials?
What Are Must-Haves for a Positive Patient Experience?
Patient advocates take center stage in this Pharma15 Live! overtime segment and share their thoughts on hybrid and decentralized clinical trials.
Moderated by BBK Worldwide Founder and Chief Development Officer Bonnie A. Brescia, this segment continues the conversation from a Patients as Partners Europe panel and answers questions asked by study sponsors in attendance. Watch now as patients answer questions about:
Establishing trust between clinical teams and study participants
Wearables and mobile apps
Use of connected technologies over a multiyear study
Defining hybrid and decentralized trials
Building and maintaining a patient panel
The segment also includes a special lightning round Q&A that provides study sponsors with additional insight into designing hybrid and decentralized clinical trials.
Phil Kelly, Bladder Cancer Patient and Advocate
Nneka Smith, Sickle Cell Disease Patient and Advocate
Thomas Smith, Cystic Fibrosis Patient and Advocate
Bonnie A. Brescia, Founder, Chief Development Officer, BBK Worldwide
Subscribe to stay connected
Share this page:
Pharma15 Live! A Candid Conversation with a Clinical Trial Participant
Podcasts & Videos
April 16, 2019
Study-Life Balance: Reenvisioning the Patient Experience